The Impact of Disease Activity Criteria on Extending Injection Intervals in Real-World Patients with Neovascular Age-Related Macular Degeneration

Applying disease activity criteria from clinical trials to clinical practice can have a significant impact on hypothetical anti-VEGF injection intervals. Consideration should be paid to which criteria are used in real-world practice to help achieve treatment burden reductions and optimal treatment outcomes seen in clinical trials.

Authors

Institutions

Publication Details

Journal
Ophthalmology and Therapy
Published
2025-02-27
DOI
https://doi.org/10.1007/s40123-025-01108-z
Citations
4
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
6.83
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Impact of Disease Activity Criteria on Extending Injection Intervals in Real-World Patients with Neovascular Age-Related Macular Degeneration

Zoe Ockrim, Avinash Gurbaxani, Pearse A. Keane, Yasir Amir Khan et al.
4 citations
Ophthalmology and Therapy
Retinal Diseases and Treatments
6.83
article

The Impact of Disease Activity Criteria on Extending Injection Intervals in Real-World Patients with Neovascular Age-Related Macular Degeneration

Zoe Ockrim, Avinash Gurbaxani, Pearse A. Keane, Yasir Amir Khan, Senthil Selvam, Konstantinos Balaskas, Adnan Tufail, Narciss Okhravi, Parul Desai, Konstantinos Bouras, Georgios Koutsocheras, Catherine Egan, Niaz Islam, Robin Hamilton, Abison Logeswaran, Evangelia Chalkiadaki, Josef Huemer, Zubin Saihan, Tjebo Heeren, Sing Yue Sim, Peter Addison, Bhairavi Bhatia, Sobha Sivaprasad, Praveen J. Patel, Khadijah Basheer, M Natkunarajah, Dhanes Thomas, Luke Nicholson, David Bessant, Waheeda Rahman, Simona Degli Esposti, Lyndon daCruz, Huang Ling, Ranjan Rajendram, Bishwanath Pal
article en
4 citations

Abstract

Applying disease activity criteria from clinical trials to clinical practice can have a significant impact on hypothetical anti-VEGF injection intervals. Consideration should be paid to which criteria are used in real-world practice to help achieve treatment burden reductions and optimal treatment outcomes seen in clinical trials.

Ophthalmology and TherapyVol. 14(4)
Moorfields Eye Hospital NHS Foundation Trust (GB), Cambridge University Hospitals NHS Foundation Trust (GB), Moorfields Eye Hospital (GB), University College London (GB)
Openalex Percentile: Top 4%
Retinal Diseases and Treatments
6.83
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.